CDC: A Paxlovid rebound may be ‘natural’ part of a COVID-19 infection

- Advertisement -


The Center for Disease Control and Prevention has issued an alert Warning about PaxLovid on Tuesday, acknowledging that a rebound in COVID-19 infections can occur after people take antivirals, although it is still unclear why this happens.

- Advertisement -

In some cases, someone who tests positive for the virus and takes a course of Paxlovid tablets may find that they will test positive again two to eight days after testing negative. This can include a recurrence of symptoms, and people who relapse are sometimes contagious to others.

- Advertisement -

The CDC said Tuesday, “A brief return of symptoms may be part of a natural history of SARS-CoV-2 (virus that causes COVID-19) infection in some individuals, independent of treatment with Paxlovid and the need for vaccination.” regardless of the situation.”

The agency continues to recommend Paxlovid for people who are at high risk of serious illness.

- Advertisement -

The Public Health Agency also reiterated the Food and Drug Administration Post That these cases do not require additional treatment with Paxlovid. (Pfizer PFE,
+0.23%
CEO Albert Boerla first told bloomberg That people going through a COVID-19 rebound after taking Paxlovid should take a second course of pills.)

The FDA authorized Paxlovid in December in a move that inevitably drew a sigh of relief through the medical community and many members of the public. Paxlovid is not only a pill that someone can take at home, taking it can dramatically reduce their chances of being hospitalized or dying.

The emergence of the Paxlovid rebound has dampened some of that enthusiasm as health care providers grapple with keeping up with the new risk factor.

“I will still take it,” Dr. Bob Wachter, chair of the Department of Medicine at the University of California, San Francisco, tweeted this week. long thread Regarding the pros and cons of taking Paxlovid, “Based primarily on my teetering, but still fairly high belief that it will reduce my chances of a dire outcome (hospitalization/death), and I believe That a rebound would be uncomfortable but ultimately super-risk.”

Other COVID-19 news to know:

Here’s what the numbers say:

An average of 108,082 cases are being reported in the US a day, which is 40% more than two weeks ago. According to the New York Times Tracker. On an average, 25,383 hospitalizations are taking place in the country a day, which is 30% more than two weeks ago. The daily death toll has fallen to an average of 331 per day, down 15% from two weeks ago. — Ciara Linnae



Credit: www.marketwatch.com /

- Advertisement -

Stay on top - Get the daily news in your inbox

DMCA / Correction Notice

Recent Articles

Related Stories

Stay on top - Get the daily news in your inbox